Protagonist Therapeutics, Inc. Skyrocketed

Wed 04 Dec 19 at 05:30 PM
Protagonist Therapeutics, Inc. Skyrocketed

Protagonist Therapeutics, Inc. (PTGX:NASDAQ) shot up at $8.11, representing a gain of 72.9%. On Tue 03 Dec 19, PTGX:NASDAQ touched a New 2-Week Low of $4.69. The stock got featured on our News Catalysts scanner on Wed 04 Dec 19 at 10:56 AM in the 'BIOTECH' category. From Tue 12 Nov 19, the stock recorded 35.71% Up Days and 33.33% Green Days

About Protagonist Therapeutics, Inc. (PTGX:NASDAQ)

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company with a proprietary peptide-based technology platform focused on discovering and developing new chemical entities to address significant unmet medical needs.

Share